Results 11 to 20 of about 2,839,497 (322)

Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial

open access: yesCritical Care, 2023
Background High dose vasopressors portend poor outcome in vasodilatory shock. We aimed to evaluate the impact of baseline vasopressor dose on outcomes in patients treated with angiotensin II (AT II).
P. Wieruszewski   +13 more
semanticscholar   +1 more source

Axial Shortening in Myopic Children after Repeated Low-Level Red-Light Therapy: Post Hoc Analysis of a Randomized Trial

open access: yesOphthalmology and Therapy, 2023
Introduction Axial length (AL) elongation in myopia is considered irreversible. We aimed to systemically report unexpected AL shortening observed in a randomized clinical trial (RCT) after repeated low-level red-light (RLRL) therapy.
Wen Wang   +15 more
semanticscholar   +1 more source

Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab

open access: yesAdvances in Therapy, 2022
Consensus definitions for clinical remission and super-response were recently established for severe asthma. Benralizumab is an interleukin-5 (IL-5) receptor α-directed monoclonal antibody for severe, uncontrolled asthma; efficacy and safety were ...
A. Menzies-Gow   +9 more
semanticscholar   +1 more source

Dulaglutide and Kidney Function-Related Outcomes in Type 2 Diabetes: A REWIND Post Hoc Analysis.

open access: yesDiabetes Care, 2023
OBJECTIVE Dulaglutide (DU) 1.5 mg was associated with improved composite renal outcomes that included new-onset macroalbuminuria in people with type 2 diabetes with previous cardiovascular disease or cardiovascular risk factors in the REWIND (Researching
F. Botros   +7 more
semanticscholar   +1 more source

Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis

open access: yesThorax, 2022
Objective To compare the effects of switching from a pressurised metered dose inhaler (pMDI)-based to a dry powder inhaler (DPI)-based maintenance therapy versus continued usual care on greenhouse gas emissions (carbon dioxide equivalents, CO2e) and ...
A. Woodcock   +7 more
semanticscholar   +1 more source

The Effects of Safinamide Adjunct Therapy on Depression and Apathy in Patients With Parkinson's Disease: Post-hoc Analysis of a Japanese Phase 2/3 Study

open access: yesFrontiers in Neurology, 2022
Background and PurposeNeuropsychiatric symptoms in Parkinson's disease (PD) have been shown to significantly affect quality of life (QOL). We investigated the impact of safinamide on depression and apathy when administered as an adjunct to levodopa in ...
Nobutaka Hattori   +6 more
doaj   +1 more source

Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6

open access: yesStroke, 2022
Background: GLP-1 RA (glucagon-like peptide-1 receptor agonists), including semaglutide, may reduce stroke risk in people with type 2 diabetes. This post hoc analysis examined the subcutaneous and oral semaglutide effects, versus placebo, on stroke and ...
W. Strain   +8 more
semanticscholar   +1 more source

Perceived Overqualification Repatriates: Post Hoc Analysis for Traditional and Alternative Forms

open access: yesJournal of International Business, Economics and Entrepreneurship, 2022
Repatriates perceived the discrepancy in utilizing their enhanced international experiences upon returning home, resulting in them being perceived as being overqualified, and led to low retention rates.
Maggie Mei Kei Chong   +2 more
doaj   +3 more sources

Assessment of the Response Profile to Hyaluronic Acid Plus Sorbitol Injection in Patients with Knee Osteoarthritis: Post-Hoc Analysis of a 6-Month Randomized Controlled Trial

open access: yesBiomolecules, 2021
In a previous randomized trial, the non-inferiority of two hyaluronic acid injections (Synolis VA versus Synvisc-One) was assessed in patients with knee OA, with a response rate of 79% for Synolis VA.
Olivier Bruyère   +3 more
doaj   +1 more source

Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial

open access: yesDiabetologia, 2022
In the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) trial, dapagliflozin reduced the risks of progressive kidney disease, hospitalised heart failure or cardiovascular death, and death from all causes in patients ...
Simke W. Waijer   +14 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy